查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1768769

全球經導管心臟瓣膜市場

Transcatheter Heart Valves
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 247 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

預計 2030 年全球經導管心臟瓣膜市場規模將達 436 億美元

全球經導管心臟瓣膜市場規模預計在2024年為173億美元，到2030年將達到436億美元，在2024-2030年的分析期間內，複合年成長率為16.6%。經導管主動脈瓣(TAV)是本報告分析的細分市場之一，預計其複合年成長率為16.9%，到分析期結束時規模將達到314億美元。經導管二尖瓣(TMV)細分市場在分析期間的複合年成長率預計為15.9%。

美國市場預計將達到 44 億美元，中國市場複合年成長率將達到 21.2%

美國經導管心臟瓣膜市場規模預計在2024年達到44億美元。作為世界第二大經濟體，中國預計到2030年市場規模將達到111億美元，在2024-2030年的分析期間內，複合年成長率為21.2%。其他值得關注的區域市場包括日本和加拿大，預計在分析期間內，這兩個市場的複合年成長率分別為11.6%和14.1%。在歐洲，預計德國市場的複合年成長率約為12.8%。

全球經導管心臟瓣膜市場－主要趨勢與促進因素摘要

為什麼經導管心臟瓣膜會改變心臟科？

經導管心臟瓣膜代表了心臟病學領域的一項突破，為患有嚴重心臟瓣膜疾病（如主動脈瓣狹窄）的患者提供了一種可替代傳統開胸手術的微創方法。與需要大胸部切口和人工心肺機的傳統外科瓣膜置換術不同，經導管心臟瓣膜置換術術是透過小切口（通常在鼠蹊部或胸部）插入導管折疊式瓣膜。一旦到位，瓣膜就會擴張並立即開始工作，無需開胸手術即可恢復正常血流。這種方法大大減少了與傳統手術相關的身體創傷和恢復時間，使其成為老年患者和不適合傳統手術的高手術風險患者的可行選擇。該領域的領先技術是經導管主動脈瓣置換術（TAVR），由於其與外科手術相比療效可靠且併發症發生率低，已被廣泛採用。 TAVR 的成功推動了其他心臟瓣膜（包括二尖瓣和三尖瓣）經導管解決方案的開發，擴大了經導管瓣膜介入治療的範圍。經導管心臟瓣膜縮短了住院時間，減輕了術後疼痛，並加快了恢復時間，不僅改善了患者的預後，也改變了心血管治療的標準。

經導管心臟瓣膜創新如何塑造心臟照護的未來？

在材料科學、器械設計和手術程序進步的推動下，經導管心臟瓣膜領域正在經歷快速創新，從而提高了這些救生器械的安全性、有效性和多功能性。最重要的創新之一是開發更耐用、更能適應複雜解剖結構的下一代經導管瓣膜。這些新器械採用了鎳鈦諾（一種形狀記憶合金）等先進材料，使瓣膜能夠自行擴張並更好地貼合患者的解剖結構，確保更好的貼合併降低洩漏和併發症的風險。另一項重要創新是使用組織工程和生物可吸收瓣膜組件，旨在提高瓣膜裝置的長期性能並最大限度地降低鈣化風險。此外，新的輸送系統和較小的導管尺寸允許透過較小的血管進行操作，進一步降低了血管併發症的風險，並使得在進行這些手術時創傷更小。 3D超音波心動圖和CT導引導航等影像技術的創新也提高了手術的精準度，使得瓣膜放置更加精確，並降低了併發症的風險。數位健康技術的整合也是一個主要趨勢，一些設備整合了感測器和無線監控系統，可以提供有關瓣膜性能和患者健康狀況的即時數據，從而實現主動管理和及時干預。

哪些挑戰影響了經導管心臟瓣膜的採用和發展？

儘管經導管心臟瓣膜具有革命性的潛力，但其廣泛應用和發展仍面臨若干重大挑戰。主要挑戰之一是這些手術的高成本。經導管瓣膜置換術，尤其是 TAVR，是一個資源密集型過程，涉及昂貴的設備、專門的培訓以及先進的成像和手術設備，這可能會限制其可及性，尤其是在低收入和農村地區。另一個挑戰是患者選擇和手術計劃的複雜性。與在直接可視化下進行的傳統外科瓣膜置換術不同，經導管手術嚴重依賴超音波心動圖、 電腦斷層掃描和螢光透視等成像方式來指導瓣膜放置。這需要高度的專業知識和精確的解剖評估，這給新操作員帶來了陡峭的學習曲線，並使這些手術在經驗不足的中心整合變得複雜。此外，經導管心臟瓣膜的長期耐用性仍然是一個問題，特別是對於可能比設備壽命更長的年輕患者。新材料和新設計旨在延長耐用性，但關於10-15年以上長期療效的數據仍然有限，因此很難確定適合這些手術的最佳患者情況。導管插入過程中的併發症風險，例如瓣週漏、瓣膜血栓症和血管損傷，也構成可能影響患者預後的挑戰。監管和報銷問題也使情況更加複雜，經導管器械的核准和報銷標準在不同地區通常存在顯著差異。

哪些因素推動了經導管心臟瓣膜市場的成長？

經導管心臟瓣膜市場的成長受到多種因素的推動，包括心血管疾病盛行率上升、全球人口老化以及設備設計和程序的技術進步。主要促進因素之一是主動脈瓣狹窄和其他心臟瓣膜疾病的盛行率不斷上升，尤其是在老年人中，他們通常具有更高的手術風險，因此更有可能受益於微創經導管治療。隨著全球人口老化，對恢復更快、併發症更少的微創治療的需求不斷增加，使經導管心臟瓣膜成為越來越受歡迎的選擇。另一個關鍵促進因素是這些設備的臨床適應症的擴大。經導管瓣膜置換術最初核准用於高風險手術候選人，現在也用於低風險患者，因為臨床試驗證明其結果與外科瓣膜置換術相當或更好。適應症的擴大顯著擴大了可以治療的患者群體，從而推動了市場成長。技術進步也在推動市場發展，可重設和可回收瓣膜、更小的輸送系統以及先進的成像工具等創新技術使手術更加安全有效。此外，心臟團隊協作方法的日益普及，即心臟病專家、外科醫生和影像專家共同製定最佳治療方案，正在改善患者的選擇和手術效果，從而提高經導管介入治療的整體成功率。在專業培訓和教育計畫的支持下，世界各地醫院專門的經導管瓣膜計畫不斷湧現，透過建設必要的基礎設施和專業知識，也促進了市場的成長。最後，人們對經導管心臟瓣膜益處的認知不斷提高，加上一些地區優惠的報銷政策，使得這些手術更容易獲得，並推動了更高的採用率。綜合起來，這些因素使經導管心臟瓣膜市場走上了強勁的成長軌道，並使其成為介入性心臟病學的重要組成部分。

部分

產品類型（經導管主動脈瓣 (TAV)、經導管二尖瓣 (TMV)）、最終使用者（醫院、導管室）

受訪公司範例

  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis

人工智慧整合

我們正在利用可操作的專家內容和人工智慧工具來改變市場和競爭情報。

Global 特定產業SLM 的典型規範，而是建立了一個從全球專家收集的內容庫，其中包括視訊錄影、部落格、搜尋引擎研究以及大量的公司、產品/服務和市場數據。

關稅影響係數

全球產業分析師根據公司總部所在國家、製造地、進出口狀況（成品和原始OEM）預測其競爭態勢的變化。這種複雜且多面向的市場動態預計將以多種方式影響競爭對手，包括銷貨成本成本 (COGS) 上升、盈利下降、供應鏈重組以及其他微觀和宏觀市場動態。

目錄

第1章調查方法

第2章執行摘要

  • 市場概覽
  • 主要企業
  • 市場趨勢和促進因素
  • 全球市場展望

第3章市場分析

  • 美國
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲國家
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他亞太地區
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 比賽

簡介目錄
Product Code: MCP17639

Global Transcatheter Heart Valves Market to Reach US$43.6 Billion by 2030

The global market for Transcatheter Heart Valves estimated at US$17.3 Billion in the year 2024, is expected to reach US$43.6 Billion by 2030, growing at a CAGR of 16.6% over the analysis period 2024-2030. Transcatheter Aortic Valve (TAV), one of the segments analyzed in the report, is expected to record a 16.9% CAGR and reach US$31.4 Billion by the end of the analysis period. Growth in the Transcatheter Mitral Valve (TMV) segment is estimated at 15.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$4.4 Billion While China is Forecast to Grow at 21.2% CAGR

The Transcatheter Heart Valves market in the U.S. is estimated at US$4.4 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$11.1 Billion by the year 2030 trailing a CAGR of 21.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.6% and 14.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.8% CAGR.

Global Transcatheter Heart Valves Market - Key Trends and Drivers Summarized

What Makes Transcatheter Heart Valves a Game-Changing Advancement in Cardiology?

Transcatheter heart valves represent a groundbreaking advancement in the field of cardiology, offering a minimally invasive alternative to traditional open-heart surgery for patients suffering from severe heart valve diseases such as aortic stenosis. Unlike conventional surgical valve replacement procedures that require a large chest incision and a heart-lung machine, transcatheter heart valve procedures involve the insertion of a collapsible valve via a catheter, typically through a small incision in the groin or chest. Once in place, the valve expands and starts functioning immediately, restoring normal blood flow without the need for open-heart surgery. This approach significantly reduces the physical trauma and recovery time associated with traditional surgery, making it a viable option for elderly patients or those with high surgical risk who may not be candidates for conventional procedures. The primary technology in this field is Transcatheter Aortic Valve Replacement (TAVR), which has gained widespread adoption due to its proven efficacy and lower complication rates compared to surgical options. The success of TAVR has spurred the development of transcatheter solutions for other heart valves, including the mitral and tricuspid valves, expanding the therapeutic scope of transcatheter valve interventions. With shorter hospital stays, reduced postoperative pain, and faster recovery times, transcatheter heart valves are not only improving patient outcomes but are also transforming the standard of care in cardiovascular treatment.

How Are Innovations in Transcatheter Heart Valves Shaping the Future of Cardiac Care?

The field of transcatheter heart valves is witnessing rapid innovation, driven by advancements in material science, device design, and procedural techniques, which are enhancing the safety, efficacy, and versatility of these life-saving devices. One of the most significant innovations is the development of next-generation transcatheter valves that offer enhanced durability and adaptability to complex anatomies. These new devices incorporate advanced materials such as nitinol-a shape-memory alloy that allows the valves to be self-expanding and more conformable to the patient’s anatomy, ensuring a better fit and reducing the risk of leaks or complications. Another key innovation is the use of tissue-engineered and bioresorbable valve components, which aim to improve the long-term performance of the devices and minimize the risk of calcification. Furthermore, new delivery systems and smaller catheter sizes are making it possible to perform these procedures with even less trauma, allowing access through smaller vessels and further reducing the risk of vascular complications. Innovations in imaging technology, such as 3D echocardiography and CT-guided navigation, are also enhancing procedural precision, enabling more accurate placement of the valve and reducing the risk of complications. The integration of digital health technologies is another major trend, with some devices incorporating sensors and wireless monitoring systems that provide real-time data on valve performance and patient health, allowing for proactive management and timely interventions.

What Challenges Are Affecting the Adoption and Development of Transcatheter Heart Valves?

Despite their transformative potential, the adoption and development of transcatheter heart valves face several significant challenges that need to be addressed to optimize their use and expand their reach. One of the primary challenges is the high cost associated with these procedures. Transcatheter valve replacement, particularly TAVR, is a resource-intensive process that involves expensive devices, specialized training, and sophisticated imaging and procedural equipment, which can limit accessibility, especially in low-income and rural settings. Another challenge is the complexity of patient selection and procedural planning. Unlike traditional surgical valve replacement, which is performed under direct visualization, transcatheter procedures rely heavily on imaging modalities such as echocardiography, CT scans, and fluoroscopy to guide valve placement. This demands a high level of expertise and precise anatomical assessment, making the learning curve steep for new operators and complicating the integration of these procedures into less experienced centers. Additionally, the long-term durability of transcatheter heart valves remains a concern, especially for younger patients who may outlive the lifespan of the device. Although newer materials and designs are aimed at extending durability, data on long-term outcomes beyond 10-15 years is still limited, making it difficult to determine the optimal patient profile for these procedures. The risk of complications, such as paravalvular leak, valve thrombosis, or vascular damage during catheter insertion, also poses challenges that can impact patient outcomes. Regulatory hurdles and reimbursement issues also complicate the landscape, as the approval and reimbursement criteria for transcatheter devices are often vary significantly between regions.

What Factors Are Driving Growth in the Transcatheter Heart Valve Market?

The growth in the transcatheter heart valve market is driven by several factors, including the rising prevalence of cardiovascular diseases, an aging global population, and technological advancements in device design and procedural techniques. One of the primary drivers is the increasing incidence of aortic stenosis and other valvular heart diseases, particularly among the elderly, who are often at higher surgical risk and thus more likely to benefit from minimally invasive transcatheter options. As the global population ages, the demand for less invasive treatments that offer faster recovery and fewer complications is rising, making transcatheter heart valves an increasingly preferred choice. Another key driver is the expansion of clinical indications for these devices. Originally approved for high-risk surgical candidates, transcatheter valve replacement procedures are now being performed in lower-risk patients, following clinical trials that demonstrated comparable or superior outcomes to surgical valve replacement. This broadening of indications is significantly expanding the patient pool eligible for these treatments, driving market growth. Technological advancements are also propelling the market, with innovations such as repositionable and retrievable valves, smaller delivery systems, and advanced imaging tools that are making the procedures safer and more effective. Furthermore, the growing adoption of heart team approaches-where cardiologists, surgeons, and imaging specialists collaborate to determine the best treatment plan-has improved patient selection and procedural outcomes, enhancing the overall success rate of transcatheter interventions. The rise of dedicated transcatheter valve programs in hospitals around the world, supported by specialized training and educational initiatives, is also contributing to market growth by building the necessary infrastructure and expertise. Lastly, increasing awareness of the benefits of transcatheter heart valves, coupled with favorable reimbursement policies in several regions, is making these procedures more accessible and driving higher adoption rates. These factors collectively indicate a robust growth trajectory for the transcatheter heart valve market, positioning it as a key component of interventional cardiology.

SCOPE OF STUDY:

The report analyzes the Transcatheter Heart Valves market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Transcatheter Aortic Valve (TAV), Transcatheter Mitral Valve (TMV)); End-Use (Hospital, Cath lab)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 16 Featured) -

  • Boston Scientific Corporation
  • Bracco Group
  • Braile Biomedica
  • Direct Flow Medical
  • Edwards Lifesciences
  • Edwards Lifesciences
  • JenaValve
  • Medtronic
  • St. Jude Medical
  • Symetis

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Transcatheter Heart Valves - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases and Aging Population Drive Demand for Transcatheter Heart Valve Procedures
    • Advancements in Valve Design and Delivery Systems Strengthen Business Case for Next-Generation Transcatheter Heart Valves
    • Growing Preference for Minimally Invasive Cardiac Interventions Expands Addressable Market for Transcatheter Heart Valves in High-Risk Patients
    • Shift towards Transcatheter Valve-in-Valve (ViV) Procedures Spurs Adoption for Complex and Repeat Interventions
    • Increasing Use of Transcatheter Aortic Valve Replacement (TAVR) Expands Market Potential in Treating Aortic Stenosis
    • Rising Adoption of Transcatheter Mitral Valve Replacement (TMVR) Propels Growth in Mitral Regurgitation Treatment
    • Growing Integration of Imaging and Navigation Technologies Enhances Precision and Success Rates of Transcatheter Valve Procedures
    • Rising Interest in Personalized and Patient-Specific Heart Valve Solutions Expands Market for Customizable Transcatheter Devices
    • Focus on Early Detection and Treatment of Heart Valve Disorders Propels Demand for Less Invasive Valve Replacement Solutions
    • Expanding Application of Transcatheter Heart Valves in Treating Congenital Heart Defects Sustains Market Growth in Pediatric and Adult Congenital Segments
    • Rising Focus on Expanding Indications Beyond Aortic and Mitral Valves Enhances Market Potential in Treating Tricuspid and Pulmonary Valve Diseases
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Transcatheter Heart Valves by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Transcatheter Aortic Valve (TAV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Transcatheter Aortic Valve (TAV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Transcatheter Mitral Valve (TMV) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Transcatheter Mitral Valve (TMV) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Transcatheter Heart Valves Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Cath lab by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Cath lab by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 17: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 18: USA Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: USA 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 20: USA Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 23: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: Canada Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: Canada 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • JAPAN
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 29: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Japan Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Japan 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • CHINA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 35: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: China Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: China 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • EUROPE
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 41: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 42: Europe Historic Review for Transcatheter Heart Valves by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Europe 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • FRANCE
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 50: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: France Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: France 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 53: France Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • GERMANY
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 56: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Germany Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Germany 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 62: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Italy Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Italy 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 68: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: UK Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: UK 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 71: UK Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 74: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Spain Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Spain 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 80: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Russia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Russia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Transcatheter Heart Valves by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 101: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Australia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Australia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • INDIA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 107: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: India Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: India 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 110: India Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 113: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: South Korea Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: South Korea 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 119: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 125: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 126: Latin America Historic Review for Transcatheter Heart Valves by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Latin America 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 134: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Argentina Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Argentina 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 140: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Brazil Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Brazil 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 146: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Mexico Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Mexico 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 152: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Rest of Latin America Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 158: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 159: Middle East Historic Review for Transcatheter Heart Valves by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Middle East 15-Year Perspective for Transcatheter Heart Valves by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 167: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Iran Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Iran 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 173: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Israel Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Israel 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 179: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Saudi Arabia Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 185: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: UAE Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: UAE 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 191: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Middle East Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030
  • AFRICA
    • Transcatheter Heart Valves Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 197: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Africa Historic Review for Transcatheter Heart Valves by Product Type - Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Africa 15-Year Perspective for Transcatheter Heart Valves by Product Type - Percentage Breakdown of Value Sales for Transcatheter Aortic Valve (TAV) and Transcatheter Mitral Valve (TMV) for the Years 2015, 2025 & 2030
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Transcatheter Heart Valves by End-Use - Hospital and Cath lab - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Transcatheter Heart Valves by End-Use - Hospital and Cath lab Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Transcatheter Heart Valves by End-Use - Percentage Breakdown of Value Sales for Hospital and Cath lab for the Years 2015, 2025 & 2030

IV. COMPETITION